Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Royaltee's uuuhhhmmmm love the smell

I am happy with both options but the second option [receiving payments on future products produced/sold by the licensed company] is the one where we will receive fees over and above the original license fee and this would be my hope.

If/when then happens, and the investing world knows it.. buckle up Dorothy

That IMO was one of the main reasons we ran to $2+.. the 'two tiered' licensing program listed on TPL's website.. once it was determined there were no recurring revs.. many investors who had planned IMO to hold longterm bailed..

I really wish Leckrone would seriously consider recurring revs/royalties.. it would be a remarkable PR tool..

jmo

Share
New Message
Please login to post a reply